Malignant tumor
Conditions
Interventions
Gold Standard:Clinical outcomes
Index test:a 
screening 
model 
based 
on 
NRS2002 
combined 
with 
inflammatory, 
biochemical, 
and 
Sponsors
Taizhou Tumor Hospital
Eligibility
Sex/Gender
Male
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients with malignant tumor confirmed by pathology; 2. Patients undergoing radiotherapy and / or chemotherapy; 3. Patients with complete clinical data: age, gender, ECoG score, height, weight, CRP, biochemical and blood routine, etc; 4. During the period of radiotherapy and chemotherapy, the patients with blood routine and biochemical examination results every two weeks; 5. Every 3 months after the end of radiotherapy and chemotherapy or according to the patient's condition, there are complete tumor follow-up results.
Exclusion criteria
Exclusion criteria: Patients with other serious diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NRS-2002;Inflammatory biomarkers;The immune indexes;White blood cell count;Platelet count;Red blood cell count;transaminase;OS; | — |
Countries
China
Contacts
Public ContactZheng Lin
Department of Radiation Oncology, Taizhou Tumor Hospital
Outcome results
None listed